Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
NUTCRACKER
Show more
Macromolecules, namely, nucleic acid sequences and proteins used for medical and/or pharmaceutical purposes; Nucleic acid sequences and chemical reagents for medical and/or pharmaceutical purposes
Class 5 – Pharmaceuticals & supplements
Status timeline
- 26 Sep 2020Application filedNew Application Entered
- 10 Feb 2021Assigned to an examining attorneyAssigned To Examiner
- 17 Feb 2021Office action issuedNon-Final Action Written
- 6 Apr 2021Approved for publicationApproved For Pub - Principal Register
- 11 May 2021Published for oppositionPublished For Opposition
- 27 Jul 2021Registered on the Principal RegisterRegistered-Principal Register
- 3 Jun 2026Ownership assignment recordedAutomatic Update Of Assignment Of Ownership
All 33 events
| 2026-07-27 | Rem1 |
| 2026-07-02 | Teas Change Of Owner Address Received |
| 2026-07-02 | Applicant/Correspondence Changes (Non-Responsive) Entered |
| 2026-07-02 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2026-07-02 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2026-07-02 | Teas Change Of Correspondence Received |
| 2026-06-03 | Automatic Update Of Assignment Of Ownership |
| 2021-07-27 | Registered-Principal Register |
| 2021-05-11 | Published For Opposition |
| 2021-05-11 | Official Gazette Publication Confirmation E-Mailed |
| 2021-04-21 | Notification Of Notice Of Publication E-Mailed |
| 2021-04-06 | Examiners Amendment -Written |
| 2021-04-06 | Examiners Amendment E-Mailed |
| 2021-04-06 | Notification Of Examiners Amendment E-Mailed |
| 2021-04-06 | Examiner's Amendment Entered |
| 2021-04-06 | Approved For Pub - Principal Register |
| 2021-04-06 | Previous Allowance Count Withdrawn |
| 2021-04-06 | Examiners Amendment -Written |
| 2021-04-06 | Examiners Amendment E-Mailed |
| 2021-04-06 | Notification Of Examiners Amendment E-Mailed |
| 2021-04-06 | Examiner's Amendment Entered |
| 2021-04-06 | Approved For Pub - Principal Register |
| 2021-02-18 | Notice Of Acceptance Of Amendment To Allege Use E-Mailed |
| 2021-02-17 | Use Amendment Accepted |
| 2021-02-17 | Non-Final Action Written |
| 2021-02-17 | Non-Final Action E-Mailed |
| 2021-02-17 | Notification Of Non-Final Action E-Mailed |
| 2021-02-10 | Assigned To Examiner |
| 2020-12-24 | Use Amendment Filed |
| 2020-12-24 | Amendment To Use Processing Complete |
| 2020-12-23 | Teas Amendment Of Use Received |
| 2020-11-01 | New Application Office Supplied Data Entered |
| 2020-09-26 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Macromolecules, namely, nucleic acid sequences and proteins used for medical and/or pharmaceutical purposes; Nucleic acid sequences and chemical reagents for medical and/or pharmaceutical purposes
First use anywhere 25 Apr 2019 · First use in commerce 25 Apr 2019
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 27 Jul 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.